6 completed, 4 recruiting, 3 terminated, 1 suspended. 4 Phase 1, 4 Phase 2, 3 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Recruiting 2, Suspended 1, Withdrawn 1 |
| Phase 2 | 4 | Recruiting 2, Suspended 1, Withdrawn 1 |
| Not applicable | 3 | Completed 2, Recruiting 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Biological Assay: new trials by email Literature Review of Biological Assay trials Research Report on Biological Assay
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer Montanide (Registered Trademark) ISA-51 VG Adjuvant, H1299 Cell Lysates, N-803 - Non-Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma | Phase 1 / Phase 2 | Suspended | National Cancer Institute (NCI) | 30 | 2026-10-27 | 2026-10-22 |
| An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's Disease VY1706 Low dose, VY1706 Mid dose, VY1706 High Dose - Alzheimer s Disease | Phase 1 | Recruiting | Voyager Therapeutics | 18 | 2026-09-03 | 2026-09-04 |
| Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD) Rituximab, Etoposide, Prednisone - Lymphoma, Lymphoma, B-Cell | Phase 2 | Recruiting | Jennifer Amengual | 30 | 2025-04-14 | 2026-05-27 |
| EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations Circulating Tumor DNA (ctDNA) Assay - Lung Cancer, EGFR Gene Mutation | Not applicable | Recruiting | Dana-Farber Cancer Institute | 1000 | 2025-04-01 | 2026-07-15 |
| Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer AdHER2DC vaccine, Pembrolizumab, N-803 - Endometrial Cancer, Cancer of Endometrium | Phase 1 / Phase 2 | Recruiting | National Cancer Institute (NCI) | 60 | 2024-05-14 | 2026-10-16 |
| Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE) Venetoclax, Dexamethasone, Daratumumab - AL Amyloidosis, Light Chain (AL) Amyloidosis | Phase 1 / Phase 2 | Withdrawn | Alfred Chung, MD | 2024-01-08 | 2025-03-06 | |
| Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen biological assays in particular on the lipid metabolism - COVID-19 Severe Pneumonia, Severe Pneumonia Due to Other Pathogene | Completed | Centre Hospitalier Universitaire Dijon | 62 | 2020-04-07 | 2026-02-02 | |
| Optimization of Frozen Embryo Transfers by Studying Progesterone on the Day of Transfer bioassay - Infertility, IVF | Completed | Centre Hospitalier Universitaire de Nīmes | 115 | 2020-03-01 | 2023-06-06 | |
| (1,3)-Béta-D-Glucan Levels at Diagnosis of Juvenile Idiopathic Arthritis and Its Correlation With Activity's Disease : a Cohort Sudy The Juvenile Disease Activity Score (JADAS), (1-3)-ß-D-Glucan (BDG) assay (Fungitell) - Juvenile Idiopathic Arthritis | Not applicable | Completed | Centre Hospitalier Universitaire, Amiens | 40 | 2019-06-11 | 2023-01-18 |
| Study of the Relation Between Lipid Myocardial Overload Evaluated by Cardiac Magnetic Resonance Imaging (MRI), Alteration of Longitudinal Myocardial Deformations by Echocardiography, and Clinical Achievements (Functional, Biological and Electrical) in Fabry Disease, and Its Outcomes. Echocardiography at T0, Exercise test, Biological assays - Fabry Disease | Unknown | University Hospital, Bordeaux | 55 | 2016-10-18 | 2017-04-21 | |
| Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing APTIMA Trichomonas vaginalis (ATV) Assay - Trichomonas Vaginalis | Completed | Gen-Probe, Incorporated | 532 | 2012-08-01 | 2014-02-06 | |
| Abbott ESA Chagas Assay Post-Market Study Testing Donor Specimens with ESA Chagas - Chagas Disease | Not applicable | Completed | Abbott Diagnostics Division | 63 | 2012-07-01 | 2014-02-20 |
| GeneSearch™ Breast Lymph Node (BLN) Assay China Registration Study GeneSearch™ Breast Lymph Node (BLN) Assay - Breast Cancer | Phase 3 | Terminated | Johnson & Johnson Medical, China | 540 | 2009-02-01 | 2013-05-30 |
| GeneSearch Breast Lymph Node (BLN) Assay Timing Study GeneSearch™ Breast Lymph Node (BLN) Assay - Breast Cancer | Terminated | Janssen Diagnostics, LLC | 233 | 2007-12-01 | 2016-01-12 | |
| GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study GeneSearch™ Breast Lymph Node (BLN) Assay - Breast Cancer | Terminated | Janssen Diagnostics, LLC | 461 | 2007-12-01 | 2016-01-12 | |
| Validation Study Using the GeneSearch BLN Assay to Test Sentinel Lymph Nodes From Patients With Breast Cancer GeneSearch™ Breast Lymph Node (BLN) Assay - Breast Cancer | Completed | Janssen Diagnostics, LLC | 80 | 2007-10-01 | 2016-01-12 |
Breast Neoplasms (4) · Neoplasm Metastasis (3) · Amyloidosis (1) · Arthritis, Juvenile (1) · Carcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Chagas Disease (1) · Endometrial Neoplasms (1) · Fabry Disease (1) · Immunoglobulin Light-chain Amyloidosis (1) · Infertility (1) · Lung Neoplasms (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoproliferative Disorders (1)
Janssen Diagnostics, LLC (3) · National Cancer Institute (NCI) (2) · Abbott Diagnostics Division (1) · Alfred Chung, MD (1) · Centre Hospitalier Universitaire Dijon (1) · Centre Hospitalier Universitaire de Nīmes (1) · Centre Hospitalier Universitaire, Amiens (1) · Dana-Farber Cancer Institute (1) · Gen-Probe, Incorporated (1) · Jennifer Amengual (1) · Johnson & Johnson Medical, China (1) · University Hospital, Bordeaux (1) · Voyager Therapeutics (1)
United States (10) · France (4) · China (1)
Scott U Adams, MS (2) · Alfred Chung, MD (1) · David S Schrump, M.D. (1) · Djamal-Dine Djeddi, MD (1) · Hoyoung M Maeng, M.D. (1) · Jennifer Amengual, MD (1) · Jennifer Reid, PhD (1) · Narjust Florez, MD (1) · Robert J. Goulet, MD (1) · Sharon Gordon, MS, MBA, MT (1) · Susan Stramer, Ph.D. (1) · Taieb Chouaki, MD (1) · Yongsheng Wang, MD (1)